Lab Cancer Immunology_DBM Basel & Medical Oncology_University Hospital Basel

Basel_Switzerland
Alfred Zippelius retweeted
Excited to make it to the cover of @NatureRevCancer (December Issue) with our review on the Molecular and Immunological drivers of ADCs! 🔦 Time to shed some light on this complex chemo delivery mechanism 🎯 Read it here: nature.com/articles/s41568-0…
3
19
110
6,157
Alfred Zippelius retweeted
What happens to an ADC after its infusion? How does it interact with tumor & immune cells, what causes response & resistance? Take a deep dive in the molecular world of ADCs though our last review, led by @AlfredZippelius and published in @NatureRevCancer. nature.com/articles/s41568-0…
3
96
336
18,705
A fusion protein that combines IL-2v + PD-1 blockade reactivates exhausted immune cells in human lung cancer samples. From @AlfredZippelius , @ClaraSerger , @DepBiomedicine , @UniBasel_en & University Hospital Basel, now in Phase I trials. Paper in Science Translational Medicine. doi.org/10.1126/scitranslmed… #Immunotherapy #CancerImmunology #FusionProtein
3
5
234
Alfred Zippelius retweeted
Would you prefer to lead a lab alone or together with a science buddy? How interesting would be a research institute where joint labs are the standard?!
46
184
1,229
171,783
Alfred Zippelius retweeted
Snow much joy at @MagdalenOxford 🦊 🎥 | @EleonoraSberg #OxfordInSnow
43
784
5,319
246,369
New #JITC article: Inhibition of Cbl-b restores effector functions of human intratumoral NK cells bit.ly/3CCabqI @AlfredZippelius
1
741
Alfred Zippelius retweeted
Excited to share that our story on PGE2-mediated control of NK cell metastasis surveillance in lung tissue is now published in @CellReports 🤝 Thanks to the many great colleagues who helped conduct this study! 👏Congratulations to first author @AMPedde! cell.com/cell-reports/fullte…
3
6
80
10,380
TODAY is the #SITC Summit on #Immunomodulation of #ADCs at 11 a.m EDT. Organizers @tlowinger @stolaney1 & @alfredzippelius will discuss the current state and future of the field. There's still time to register for FREE! Save your spot for today's summit: go.sitcancer.org/3J157vT
2
4
980
Alfred Zippelius retweeted
.@LurieCancer’s 2024 Translational Research in Malignancies Symposium was a great success! Thank you to all of today’s speakers for their insights focused on resistance to cancer treatment. View the topics here: cancer.northwestern.edu/docs…
3
6
3,119
Alfred Zippelius retweeted
Great work by Ronja Wieboldt and Natalia Mantuano in our lab @DepBiomedicine . They show that myeloid-derived suppressors are inhibiting efficient anti-tumor immunity by secreting CCL2 induced by sialic acid-Siglec interactions. #glycotime rdcu.be/dAt5I
1
1
7
916
Amazing joint achievement ! @lab_binder @LabMinguet and Chiorazzi Lab @NatureComms @UniSpitalBasel @CIBSS_UniFR Florian Märkl @SophiaStock_ @i_piseddu
3
12
1,766
Alfred Zippelius retweeted
New immune cell engagers for cancer immunotherapy | Nature Reviews Immunology nature.com/articles/s41577-0…
41
147
14,858
Alfred Zippelius retweeted
Congrats @LabWithers and @ClatworthyLab! Still impressed how rapidly NKs change in the TME
2
1
454
Alfred Zippelius retweeted
Merci++ à Jennifer Blum et Emmanuel Ostia
▫️Le portrait du mois | mediscoop.net▫️ Eric Vivier - Président de Paris Saclay Cancer Cluster « L’immunologiste qui bâtit des ponts » #dirigeant #santé #parissaclay #cancer ⬇️ lire le portrait ⬇️ bit.ly/3SfDUJY
3
16
1,556
New #JITC position article and guidelines: Corticosteroid-resistant immune-related adverse events: a systematic review bit.ly/3u0egRp @LImmunotherapy @AlfredZippelius @cappelliMD @DrJNaidoo
29
39
6,618
Alfred Zippelius retweeted
Our latest story is out in @CellPressImmunity today!! We show that Stat5 opposes Tox and rewires exhausted CD8s towards more durably protective effector-like states. Shout out to my co-authors, @parkerici and @EJohnWherry Key take-home messages in the 🧵⬇️ cell.com/immunity/ppt/S1074-…
7
81
294
71,197
SNSF Starting Grants Call 2024 The call is aimed at researchers who intended to apply for an #ERCStartingGrant in 2023 to conduct an independent scientific project and lead a research team in Switzerland. Submission deadline: 1 February 2024 sohub.io/01rm
36
63
18,825
Alfred Zippelius retweeted
#OnlineFirst: Read the In the Spotlight commentary— Unraveling #Tcell exhaustion: genetic screening meets in vitro modeling, by @AlfredZippelius, @MarcelTrefny, @priska_adm, and Schmid describing a recent @SciImmunology paper from the @EJohnWherry group. bit.ly/49iKo2s
5
7
1,480